Aldeyra Therapeutics

1 Follower


Aldeyra Therapeutics develops treatments for aldehyde toxicity-related diseases including Sjögren-Larsson Syndrome (SLS) and noninfectious anterior uveitis.


Add photos to showcase Aldeyra Therapeutics’s culture


Add Aldeyra Therapeutics’s values

Insider experiences

Share your experience of working at Aldeyra Therapeutics

Todd C. Brady
CEO & President
Christopher Pearson
Vice President, Commercial Development and Strategy
David B. McMullin
Chief Commercial Officer
David J. Clark
Chief Medical Officer
David Noskowitz
Vice President, Regulatory Affairs
Lise L. Kjems
Vice President, Clinical Development
Stephen G. Machatha
Senior Vice President, Technical Operations

Add your teams to show how people work together at Aldeyra Therapeutics

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure